We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Commissioner nominee Scott Gottlieb will recuse himself for one year from decisions relating to more than 20 companies, including large drugmakers, according to his ethics disclosure form. Read More
South Korean biosimilars firm Celltrion is challenging the validity of four Genentech patents for combination therapies to treat metastatic breast cancer. Read More
Sen. Claire McCaskill (D-Mo.) has opened a congressional investigation into the top five manufacturers of opioids, saying the overdose epidemic is a “direct result” of the companies’ sales and marketing strategies over the past two decades. Read More